Investor Presentaiton slide image

Investor Presentaiton

5. Hitech Integration Hitech Diagnostic Centre Revenue Rs. (In Crs.) Covid Non-Covid +15% 124 123 50 83 78 71 50 22 METROPOLIS The Pathology Specialist Revenue strategy to aid double digit growth ✓ Dual brand strategy in Chennai while single brand in rest of TN & Karnataka. Plan to launch 100 centers in FY23 ✓ Increasing contribution of speciality tests by Widening the Test Menu and improve the Product mix. ✓ Boost sales by extending Metropolis' digital marketing, app, website and other tools to enhance effectiveness of Hitech's sales effort 100 74 ✓ ✓ FY18 FY19 FY20 FY21 FY22 Using Hitech's local lab infra, improve TAT for customers. Wellness is a small portion in Hitech currently as against around 7% wellness contribution of Metropolis. Target to increase wellness to Metropolis level. Key Financial Highlights of Hitech Diagnostic Centre ✓ Hitech's non-covid business grew by 35% in FY22 to Rs. 100 crs while covid revenue dropped by 56% in FY22 to Rs. 22 crs. ✓ Non-covid revenue contribution stood at 82% of the total revenue in FY22 which is sustainable in nature ✓ This robust performance is on the back of its strong B2C connect Key levers to increase margins Increase B2C revenue mix from current 65% to over 70% Raw Material cost synergies in procurement with economies of scale Better Lab utilization with higher volumes ✓ Rationalization in Infrastructure, manpower, admin & logistic costs Usage of Metropolis IT systems and processes to improve productivity Margin is expected to grow by 3-4%. 35
View entire presentation